2m 2m 2m 2m 2m 2m 2m
CDT EQUITY (CDT)
NASDAQ
$1.14-$0.01 (-1.30%)
Price as of Jun 23, 2026 7:59 PM EDT- $7.3MMarket Cap
- -99.75%1-Year Change
- BiotechnologyIndustry
CDT EQUITY (CDT)
$1.14-$0.01 (-1.30%)
CDT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.15 | ||
Change | -$0.35 (-23.33%) | ||
Open | $1.55 | ||
High | $1.60 | ||
Low | $1.11 | ||
Previous Close | $1.50 | ||
Volume | 6,748,310 | ||
30-Day Average Volume | 21,080,443 | ||
1-Week Change | 60.21% | ||
1-Month Change | 9.52% | ||
1-Year Change | -99.75% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 4.9M | ||
Total Assets | $5.7M | ||
Market Cap | $7.3M | ||
Enterprise Value | $11.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$21.6M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$21.5M | ||
EBITDA | -$21.2M | ||
Net Working Capital | -$8.4M | ||
EPS | $101.66 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | 0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 03/27/2026 | ||
Earnings & Revenue